Seelos Therapeutics Inc (SEELQ)

Currency in USD
0.001
0.000(0.00%)
Closed·
SEELQ Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Trading near 52-week Low
Fair Value
Day's Range
0.0010.001
52 wk Range
0.0018.858
Key Statistics
Prev. Close
-
Open
0.001
Day's Range
0.001-0.001
52 wk Range
0.001-8.858
Volume
-
Average Volume (3m)
2.02K
1-Year Change
-99.98%
Book Value / Share
-157.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SEELQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Seelos Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Seelos Therapeutics Inc Company Profile

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company’s lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene and alpha synuclein; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; SLS-007, a peptidic inhibitor for NACore Parkinson disease; and SLS-009, a protein targeted autophagy for Alzheimer disease. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York. On November 16, 2024, Seelos Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Compare SEELQ to Peers and Sector

Metrics to compare
SEELQ
Peers
Sector
Relationship
P/E Ratio
0.0x−0.3x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x1.7x3.3x
Upside (Analyst Target)
-173.2%45.4%
Fair Value Upside
Unlock19.7%7.7%Unlock

Earnings

Latest Release
Aug 14, 2024
EPS / Forecast
1.98 / -0.05
Revenue / Forecast
376.00K / --
EPS Revisions
Last 90 days

SEELQ Income Statement

People Also Watch

25.91
CNC
-0.61%
156.00
CAH
+0.50%
115.98
LEN
+3.39%
84.11
QRVO
+0.61%
1.130
XPON
-3.42%

FAQ

What Stock Exchange Does Seelos Therapeutics Trade On?

Seelos Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Seelos Therapeutics?

The stock symbol for Seelos Therapeutics is "SEELQ."

What Is the Seelos Therapeutics Market Cap?

As of today, Seelos Therapeutics market cap is 136.00.

What Is Seelos Therapeutics's Earnings Per Share (TTM)?

The Seelos Therapeutics EPS (TTM) is 47.06.

From a Technical Analysis Perspective, Is SEELQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Seelos Therapeutics Stock Split?

Seelos Therapeutics has split 6 times.

How Many Employees Does Seelos Therapeutics Have?

Seelos Therapeutics has 8 employees.

What is the current trading status of Seelos Therapeutics (SEELQ)?

As of 03 Aug 2025, Seelos Therapeutics (SEELQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 8.86.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.